Biotech found 30% of in vivo studies redundant — agent prompt to review studies pre-execution

nlarusstone · x · 2026-10-25

Day 6 of the "an agent a day" series: a biotech company used Benchling AI to discover 30% of its in vivo studies were redundant or wasteful — millions of dollars and months of time lost. The author argues every animal study should be reviewed by an agent (or team of agents) before execution, and shares a sample prompt: an In Vivo Study Review agent that runs before execution, checks for duplicates, assesses statistical significance of readouts, and suggests concrete design changes.

Original post →

More from coding & agent

coding & agent channel →